...

首页> 外文期刊>Journal for ImmunoTherapy of Cancer >P27. Alemtuzumab (anti-CD52 monoclonal antibody) as single-agent therapy in patients with relapsed/refractory chronic lymphocytic leukaemia (CLL) – a single region experience on consecutive patients

【24h】

P27. Alemtuzumab (anti-CD52 monoclonal antibody) as single-agent therapy in patients with relapsed/refractory chronic lymphocytic leukaemia (CLL) – a single region experience on consecutive patients

机译：P27。 Alemtuzumab（抗CD52单克隆抗体）作为复发/难治性慢性淋巴细胞白血病（CLL）患者的单药治疗–连续患者的单区域经验

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal for ImmunoTherapy of Cancer》 |2014年第s2期|共页
作者
S Eketorp Sylvan; J Lundin; M Ipek; M Palma; C Karlsson; L Hansson;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Aleintuiumab (anti-CD52 monoclonal antibody) ms single-agent therapy in patients with relapsed/refractory chronic lymphocytic leukaemia (CLL)-a single region experience on consecutive patients [J] . S. Eketorp Sylvan, J. Lundin, M. Ipek, Annals of hematology . 2014,第10期

机译：复发性/难治性慢性淋巴细胞白血病（CLL）患者的Aleintuiumab（抗CD52单克隆抗体）ms单药治疗-连续患者的单区域经验
2. The addition of CD20 monoclonal antibodies to lenalidomide improves response rates and survival in relapsed/refractory patients with chronic lymphocytic leukaemia relative to lenalidomide monotherapy - the MD Anderson Cancer Center experience [J] . Thompson Philip A., Rozovski Uri, Keating Michael J., British Journal of Haematology . 2015,第2期

机译：与来那度胺单药治疗相比，向来那度胺添加CD20单克隆抗体可提高复发率/难治性慢性淋巴细胞白血病患者的应答率和生存率-MD安德森癌症中心的经验
3. CHANGES IN SERUM COMPLEMENT ACTIVITY DURING ANTI-CD20 AND ANTI-CD52 MONOCLONAL ANTIBODY THERAPY IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) [J] . Stasilojc Grzegorz, Felberg Anna, Taszner Michal, Molecular Immunology . 2019,第期

机译：慢性淋巴细胞白血病患者抗CD20和抗CD52单克隆抗体治疗期间血清补体活性的变化（CLL）
4. Efficiency and Toxmcity of the Fludarabine and Cyclo- Phosphamide Combined Therapy in Relapsed/ Resistant Patients with B-cell Chronic Lymphocytic Leukaemia (CLL)-Polish Multicenter Study [C] . M. Kowal, A. Dmoszynska, D. Jawniak, European Haematology Association . 2002

机译：B-Cell慢性淋巴细胞白血病（CLL） - 渗透多中心研究的复发/抗性患者复发/抗性患者的氟氮胺碱和环磷酰胺联合治疗的效率和毒性
5. Experiences of Single-session Improvisational Group Music Therapy: Therapist and Patient Reflections from Inpatient Psychiatry [D] . Chen, Yu-Ying 2019

机译：单节期即兴团体音乐治疗的经验：住院精神病学的治疗师和患者的思考
6. P27. Alemtuzumab (anti-CD52 monoclonal antibody) as single-agent therapy in patients with relapsed/refractory chronic lymphocytic leukaemia (CLL) – a single region experience on consecutive patients [O] . S Eketorp Sylvan, J Lundin, M Ipek, 2014

机译：P27。 Alemtuzumab（抗CD52单克隆抗体）作为复发/难治性慢性淋巴细胞白血病（CLL）患者的单药治疗–连续患者的单区域经验
7. P27. Alemtuzumab (anti-CD52 monoclonal antibody) as single-agent therapy in patients with relapsed/refractory chronic lymphocytic leukaemia (CLL) – a single region experience on consecutive patients [O] . S Sylvan, J Lundin, M Ipek, 2014

机译：P27。 Alemtuzumab（抗CD52单克隆抗体）作为复发/难治性慢性淋巴细胞白血病（CLL）患者的单药治疗–连续患者的单区域经验

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号